Aqurio Named Finalist for 2026 AI Startup of the Year
Aqurio is a finalist in the AI Startup of the Year category at the 2026 A.I. Awards. Winners will be announced on October 13.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Aqurio is a finalist in the AI Startup of the Year category at the 2026 A.I. Awards. Winners will be announced on October 13.
Tsingke introduced a high throughput workflow for testing large libraries of proteins and antibodies designed with AI. It covers gene synthesis, expression, screening, purification and binding analysis.
QC Healthcare will add Sanguina's AI fingernail analysis technology to its pediatric and adult telehealth platforms for blood health screening and monitoring.
A Deerborne Group survey found that 62% of diagnostics and life sciences executives reported less analytical work with AI, while 54% saw no meaningful improvement in decision quality.
Rhythm AI reported that 90% of patients treated with its STAR mapping system during repeat ablation procedures were free from atrial fibrillation after one year.
Ping An GlobalCare combines AI translation with online consultations, hospital transfers and in person assistance for expatriates in China.
Cellular Intelligence appointed Yann LeCun, Bob Langer, Jens Nielsen and Fabian Theis to its Scientific Advisory Board. The company is developing a foundation model designed to predict cellular behavior.
Clinical AI company Amigo is rebranding as Concurrence and expanding its platform for health systems, biopharma companies, and public health organizations.
CIPRA.ai and Murata are collaborating on wearable tools that combine sensing technology with digital twins and AI for chronic disease management.
Brainomix has been selected for Future Fifty, an invitation only programme for growing UK technology companies.
Rutgers University and RWJBarnabas Health will open an innovation hub that gives students access to AWS cloud and AI tools for health care projects.
Vetology rebuilt its 94 veterinary radiology classifiers using a new architecture that analyzes information within individual images and across linked images in a study.
NAVER D2SF invested in precision medicine company ImpriMed through a $10 million Series A2 bridge round led by LB Investment.
UNC Lineberger will use a $40 million grant from the OpenAI Foundation to train AI models for designing personalized cancer vaccines.
Healthcare Triangle will serve as the US technology and capital markets partner for the Kanzun-ARCB Growth Fund, which connects Malaysian healthcare companies with Middle Eastern investors and potential US market opportunities.
The Gates Foundation will spend at least $1 billion over two years on AI tools and access across education, health care, agriculture, and digital infrastructure.
Insilico Medicine released an open toolkit with an AI benchmark, specialized language models and an agent platform for aging research. Its top model recorded the highest overall score among 26 systems tested on LongevityBench.
Beacon-2 predicts the efficacious human dose of a small molecule from its chemical structure and is available through the Compass platform.
Gigasheet introduces an AI agent that compares healthcare claims with published commercial rates and geographically adjusted Medicare reimbursement data.
Canary Speech was included among TIME and Statista's top 500 health technology companies for the second consecutive year.